Quest Accounts Payable vs Total Stockholder Equity Analysis

DGX Stock  USD 163.89  2.57  1.59%   
Quest Diagnostics financial indicator trend analysis is much more than just breaking down Quest Diagnostics prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Quest Diagnostics is a good investment. Please check the relationship between Quest Diagnostics Accounts Payable and its Total Stockholder Equity accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Quest Diagnostics Incorporated. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

Accounts Payable vs Total Stockholder Equity

Accounts Payable vs Total Stockholder Equity Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Quest Diagnostics Accounts Payable account and Total Stockholder Equity. At this time, the significance of the direction appears to have strong relationship.
The correlation between Quest Diagnostics' Accounts Payable and Total Stockholder Equity is 0.71. Overlapping area represents the amount of variation of Accounts Payable that can explain the historical movement of Total Stockholder Equity in the same time period over historical financial statements of Quest Diagnostics Incorporated, assuming nothing else is changed. The correlation between historical values of Quest Diagnostics' Accounts Payable and Total Stockholder Equity is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Accounts Payable of Quest Diagnostics Incorporated are associated (or correlated) with its Total Stockholder Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Stockholder Equity has no effect on the direction of Accounts Payable i.e., Quest Diagnostics' Accounts Payable and Total Stockholder Equity go up and down completely randomly.

Correlation Coefficient

0.71
Relationship DirectionPositive 
Relationship StrengthSignificant

Accounts Payable

An accounting item on the balance sheet that represents Quest Diagnostics obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Quest Diagnostics are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.
Most indicators from Quest Diagnostics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Quest Diagnostics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Quest Diagnostics Incorporated. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
At this time, Quest Diagnostics' Discontinued Operations is fairly stable compared to the past year. Tax Provision is likely to rise to about 266.4 M in 2024, whereas Selling General Administrative is likely to drop slightly above 1.5 B in 2024.
 2021 2022 2023 2024 (projected)
Gross Profit4.2B3.4B3.1B2.7B
Total Revenue10.8B9.9B9.3B6.9B

Quest Diagnostics fundamental ratios Correlations

0.970.790.870.990.710.910.860.670.610.990.110.610.940.81-0.090.990.840.25-0.80.990.380.870.360.820.92
0.970.750.910.930.650.950.810.560.590.970.150.590.850.83-0.030.970.750.26-0.770.990.360.810.50.840.9
0.790.750.770.790.660.730.750.660.440.79-0.340.440.810.56-0.230.740.730.17-0.710.780.330.680.390.540.83
0.870.910.770.820.660.840.730.560.640.850.130.640.820.71-0.040.830.740.28-0.660.90.380.820.720.70.87
0.990.930.790.820.730.860.880.710.610.980.060.610.950.77-0.130.970.860.21-0.80.960.370.870.270.780.91
0.710.650.660.660.730.520.840.770.760.67-0.160.760.760.39-0.580.660.82-0.03-0.710.690.810.770.450.340.63
0.910.950.730.840.860.520.750.40.330.940.190.330.750.90.070.930.620.39-0.750.940.30.620.440.910.89
0.860.810.750.730.880.840.750.640.630.86-0.030.630.820.73-0.20.830.710.17-0.950.830.640.730.410.690.85
0.670.560.660.560.710.770.40.640.70.61-0.180.70.810.29-0.480.620.890.09-0.510.630.540.840.150.280.5
0.610.590.440.640.610.760.330.630.70.52-0.041.00.680.26-0.30.550.68-0.18-0.50.590.520.880.490.240.45
0.990.970.790.850.980.670.940.860.610.520.120.520.910.85-0.060.990.790.27-0.810.980.350.80.330.860.93
0.110.15-0.340.130.06-0.160.19-0.03-0.18-0.040.12-0.040.070.460.620.180.010.570.140.17-0.080.08-0.030.480.01
0.610.590.440.640.610.760.330.630.71.00.52-0.040.680.26-0.30.550.68-0.18-0.50.590.520.880.490.240.45
0.940.850.810.820.950.760.750.820.810.680.910.070.680.68-0.140.90.930.18-0.690.910.380.930.270.680.85
0.810.830.560.710.770.390.90.730.290.260.850.460.260.680.370.850.480.57-0.690.840.270.540.310.990.8
-0.09-0.03-0.23-0.04-0.13-0.580.07-0.2-0.48-0.3-0.060.62-0.3-0.140.37-0.03-0.40.390.18-0.04-0.57-0.21-0.090.39-0.02
0.990.970.740.830.970.660.930.830.620.550.990.180.550.90.85-0.030.80.27-0.770.990.350.820.310.860.88
0.840.750.730.740.860.820.620.710.890.680.790.010.680.930.48-0.40.80.1-0.570.810.480.90.230.480.7
0.250.260.170.280.21-0.030.390.170.09-0.180.270.57-0.180.180.570.390.270.1-0.10.290.110.10.050.570.22
-0.8-0.77-0.71-0.66-0.8-0.71-0.75-0.95-0.51-0.5-0.810.14-0.5-0.69-0.690.18-0.77-0.57-0.1-0.77-0.54-0.59-0.4-0.66-0.81
0.990.990.780.90.960.690.940.830.630.590.980.170.590.910.84-0.040.990.810.29-0.770.370.850.430.850.91
0.380.360.330.380.370.810.30.640.540.520.35-0.080.520.380.27-0.570.350.480.11-0.540.370.420.460.190.34
0.870.810.680.820.870.770.620.730.840.880.80.080.880.930.54-0.210.820.90.1-0.590.850.420.380.540.7
0.360.50.390.720.270.450.440.410.150.490.33-0.030.490.270.31-0.090.310.230.05-0.40.430.460.380.260.46
0.820.840.540.70.780.340.910.690.280.240.860.480.240.680.990.390.860.480.57-0.660.850.190.540.260.79
0.920.90.830.870.910.630.890.850.50.450.930.010.450.850.8-0.020.880.70.22-0.810.910.340.70.460.79
Click cells to compare fundamentals

Quest Diagnostics Account Relationship Matchups

Quest Diagnostics fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets12.8B14.0B13.6B12.8B14.0B8.5B
Short Long Term Debt Total5.3B4.7B4.7B4.6B5.4B3.1B
Other Current Liab778M991M1.1B978M852M667.4M
Total Current Liabilities2.0B1.8B1.8B1.6B1.8B1.2B
Total Stockholder Equity5.6B6.8B6.4B5.9B6.3B3.9B
Property Plant And Equipment Net2.0B2.2B2.3B2.4B2.4B2.5B
Net Debt4.1B3.5B3.8B4.3B4.7B2.7B
Retained Earnings8.2B9.3B7.6B8.3B8.8B9.3B
Accounts Payable263M446M357M324M378M288.0M
Cash1.2B1.2B872M315M686M720.3M
Non Current Assets Total10.4B11.0B10.9B10.9B11.7B6.9B
Non Currrent Assets Other160M176M163M144M198M176.0M
Cash And Short Term Investments1.2B1.2B872M315M686M720.3M
Net Receivables1.1B1.5B1.4B1.2B1.2B892.3M
Liabilities And Stockholders Equity12.8B14.0B13.6B12.8B14.0B8.5B
Non Current Liabilities Total5.1B5.4B5.3B5.3B5.8B3.3B
Inventory123M223M208M192M190M104.0M
Other Current Assets112M157M223M196M286M227.8M
Other Stockholder Equity(2.5B)(2.5B)(1.2B)(2.4B)(2.5B)(2.4B)
Total Liab7.1B7.1B7.0B6.8B7.6B4.6B
Property Plant And Equipment Gross2.0B2.2B2.3B2.4B5.8B6.1B
Total Current Assets2.5B3.1B2.7B1.9B2.4B1.6B
Accumulated Other Comprehensive Income(48M)(59M)(39M)(21M)(14M)(14.7M)
Short Term Debt949M296M269M247M585M614.3M
Intangible Assets1.2B1.1B1.2B1.1B1.2B968.0M
Other Liab683M847M792M812M933.8M472.6M
Other Assets64M1.3B163M144M165.6M196.9M
Long Term Debt4.0B4.0B4.0B4.0B4.4B3.0B
Property Plant Equipment1.5B1.6B2.3B2.4B2.7B2.8B
Good Will6.6B6.9B7.1B7.2B7.7B5.7B
Treasury Stock(5.2B)(5.4B)(3.5B)(4.7B)(4.2B)(4.4B)
Net Tangible Assets(1.6B)(700M)(1.8B)(1.9B)(2.1B)(2.2B)
Noncontrolling Interest In Consolidated Entity46M50M39M37M42.6M34.3M
Retained Earnings Total Equity8.2B9.3B7.6B8.3B9.5B6.6B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Quest Stock Analysis

When running Quest Diagnostics' price analysis, check to measure Quest Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quest Diagnostics is operating at the current time. Most of Quest Diagnostics' value examination focuses on studying past and present price action to predict the probability of Quest Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quest Diagnostics' price. Additionally, you may evaluate how the addition of Quest Diagnostics to your portfolios can decrease your overall portfolio volatility.